{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:45:21Z","timestamp":1793306721497,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12664-025-01833-0","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T12:57:24Z","timestamp":1754139444000},"page":"192-201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Sex and gender differences in metabolic dysfunction-associated liver disease"],"prefix":"10.1007","volume":"45","author":[{"given":"Rishitha","family":"Penmetsa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Kapil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6264-2573","authenticated-orcid":false,"given":"Lisa B.","family":"VanWagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"1833_CR1","doi-asserted-by":"publisher","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77:1335\u201347. https:\/\/doi.org\/10.1097\/HEP.0000000000000004.","DOI":"10.1097\/HEP.0000000000000004"},{"key":"1833_CR2","doi-asserted-by":"publisher","first-page":"eadi0759","DOI":"10.1126\/scitranslmed.adi0759","volume":"15","author":"S Wang","year":"2023","unstructured":"Wang S, Friedman SL. Found in translation-fibrosis in metabolic dysfunction-associated steatohepatitis (MASH). Sci Transl Med. 2023;15:eadi0759. https:\/\/doi.org\/10.1126\/scitranslmed.adi0759.","journal-title":"Sci Transl Med"},{"key":"1833_CR3","doi-asserted-by":"publisher","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology. 2019;70:1457\u201369. https:\/\/doi.org\/10.1002\/hep.30626.","DOI":"10.1002\/hep.30626"},{"key":"1833_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/tbm\/ibad014","volume":"14","author":"E Barr","year":"2024","unstructured":"Barr E, Popkin R, Roodzant E, Jaworski B, Temkin SM. Gender as a social and structural variable: research perspectives from the National Institutes of Health (NIH). Transl Behav Med. 2024;14:13\u201322. https:\/\/doi.org\/10.1093\/tbm\/ibad014.","journal-title":"Transl Behav Med"},{"key":"1833_CR5","doi-asserted-by":"publisher","unstructured":"Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010;51:1972\u20138. https:\/\/doi.org\/10.1002\/hep.23527.","DOI":"10.1002\/hep.23527"},{"key":"1833_CR6","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.12688\/f1000research.12417.2","volume":";6","author":"U Summart","year":"2017","unstructured":"Summart U, Thinkhamrop B, Chamadol N, Khuntikeo N, Songthamwat M, Kim CS. Gender differences in the prevalence of nonalcoholic fatty liver disease in the Northeast of Thailand: a population-based cross-sectional study. F1000Res. 2017;6:1630. https:\/\/doi.org\/10.12688\/f1000research.12417.2.","journal-title":"F1000Res"},{"key":"1833_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/apt.17892","volume":"59","author":"T Prabhakar","year":"2024","unstructured":"Prabhakar T, Prasad M, Kumar G, et al. High prevalence of MAFLD in general population: a large cross-sectional study calls for concerted public health action. Aliment Pharmacol Ther. 2024;59:843\u201351. https:\/\/doi.org\/10.1111\/apt.17892.","journal-title":"Aliment Pharmacol Ther"},{"key":"1833_CR8","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. J Hepatol. 2018;69:896\u2013904. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.036.","journal-title":"J Hepatol"},{"key":"1833_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","volume":"79","author":"MH Le","year":"2023","unstructured":"Le MH, Le DM, Baez TC, et al. Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons. J Hepatol. 2023;79:287\u201395. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.040.","journal-title":"J Hepatol."},{"key":"1833_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1440-1746.2005.04086.x","volume":"21 1 Pt 1","author":"SH Park","year":"2006","unstructured":"Park SH, Jeon WK, Kim SH, et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2006;21 1 Pt 1:138\u201343. https:\/\/doi.org\/10.1111\/j.1440-1746.2005.04086.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"1833_CR11","doi-asserted-by":"publisher","first-page":"108024","DOI":"10.1016\/j.maturitas.2024.108024","volume":"186","author":"SA Polyzos","year":"2024","unstructured":"Polyzos SA, Goulis DG. Menopause and metabolic dysfunction-associated steatotic liver disease. Maturitas. 2024;186:108024. https:\/\/doi.org\/10.1016\/j.maturitas.2024.108024.","journal-title":"Maturitas."},{"key":"1833_CR12","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.cgh.2010.08.005","volume":"8","author":"A Suzuki","year":"2010","unstructured":"Suzuki A, Abdelmalek MF, Unalp-Arida A, et al. Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2010;8:1062\u20139. https:\/\/doi.org\/10.1016\/j.cgh.2010.08.005.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"1833_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.semcdb.2021.04.026","volume":"126","author":"DAM Joye","year":"2022","unstructured":"Joye DAM, Evans JA. Sex differences in daily timekeeping and circadian clock circuits. Semin Cell Dev Biol. 2022;126:45\u201355. https:\/\/doi.org\/10.1016\/j.semcdb.2021.04.026.","journal-title":"Semin Cell Dev Biol."},{"key":"1833_CR14","doi-asserted-by":"publisher","first-page":"154337","DOI":"10.1016\/j.metabol.2020.154337","volume":"111S","author":"A Mukherji","year":"2020","unstructured":"Mukherji A, Dachraoui M, Baumert TF. Perturbation of the circadian clock and pathogenesis of NAFLD. Metabolism. 2020;111S:154337. https:\/\/doi.org\/10.1016\/j.metabol.2020.154337.","journal-title":"Metabolism"},{"key":"1833_CR15","doi-asserted-by":"publisher","first-page":"100270","DOI":"10.1016\/j.jnha.2024.100270","volume":"28","author":"DH Son","year":"2024","unstructured":"Son DH, Kwon YJ, Lee JH. Sex difference in skeletal muscle mass in relation to metabolic dysfunction-associated steatotic liver disease: a propensity score matching study. J Nutr Health Aging. 2024;28:100270. https:\/\/doi.org\/10.1016\/j.jnha.2024.100270.","journal-title":"J Nutr Health Aging."},{"key":"1833_CR16","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.clnu.2024.07.006","volume":"43","author":"X Li","year":"2024","unstructured":"Li X, He J, Sun Q. The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis. Clin Nutr. 2024;43:2005\u201316. https:\/\/doi.org\/10.1016\/j.clnu.2024.07.006.","journal-title":"Clin Nutr."},{"key":"1833_CR17","doi-asserted-by":"publisher","unstructured":"DiStefano JK. NAFLD and NASH in postmenopausal women: implications for diagnosis and treatment. Endocrinology. 2020;161:bqaa134. https:\/\/doi.org\/10.1210\/endocr\/bqaa134.","DOI":"10.1210\/endocr\/bqaa134"},{"key":"1833_CR18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/ijo.2017.50","volume":"41","author":"S Hart-Unger","year":"2017","unstructured":"Hart-Unger S, Arao Y, Hamilton KJ, et al. Hormone signaling and fatty liver in females: analysis of estrogen receptor alpha mutant mice. Int J Obes (Lond). 2017;41:945\u201354. https:\/\/doi.org\/10.1038\/ijo.2017.50.","journal-title":"Int J Obes (Lond)."},{"key":"1833_CR19","doi-asserted-by":"publisher","unstructured":"Lee C, Kim J, Jung Y. Potential therapeutic application of estrogen in gender disparity of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. Cells. 2019;8:1259. https:\/\/doi.org\/10.3390\/cells8101259.","DOI":"10.3390\/cells8101259"},{"key":"1833_CR20","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.molmed.2024.05.013","volume":"30","author":"A Cherubini","year":"2024","unstructured":"Cherubini A, Della Torre S, Pelusi S, Valenti L. Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease. Trends Mol Med. 2024;30:1126\u201336. https:\/\/doi.org\/10.1016\/j.molmed.2024.05.013.","journal-title":"Trends Mol Med"},{"key":"1833_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/jpr3.12054","volume":"5","author":"A Steiger","year":"2024","unstructured":"Steiger A, VanderVeen NT, Kang EH, Weimer AK. Resolution of metabolic dysfunction-associated steatohepatitis with estradiol in a transgender female: a case report. JPGN Rep. 2024;5:223\u20137. https:\/\/doi.org\/10.1002\/jpr3.12054.","journal-title":"JPGN Rep."},{"key":"1833_CR22","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.4158\/EP161370.OR","volume":"22","author":"Y Sofer","year":"2016","unstructured":"Sofer Y, Osher E, Limor R, et al. Gender determines serum free cortisol: higher levels in men. Endocr Pract. 2016;22:1415\u201321. https:\/\/doi.org\/10.4158\/EP161370.OR.","journal-title":"Endocr Pract"},{"key":"1833_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1365-2265.2006.02466.x","volume":"64","author":"G Targher","year":"2006","unstructured":"Targher G, Bertolini L, Rodella S, Zoppini G, Zenari L, Falezza G. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf). 2006;64:337\u201341. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02466.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1833_CR24","doi-asserted-by":"publisher","unstructured":"Charlton M, Angulo P, Chalasani N, et al. Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology. 2008;47:484\u201392. https:\/\/doi.org\/10.1002\/hep.22063.","DOI":"10.1002\/hep.22063"},{"key":"1833_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00109-019-01842-5","volume":"98","author":"CJ Teixeira","year":"2020","unstructured":"Teixeira CJ, Veras K, de Oliveira Carvalho CR. Dehydroepiandrosterone on metabolism and the cardiovascular system in the postmenopausal period. J Mol Med (Berl). 2020;98:39\u201357. https:\/\/doi.org\/10.1007\/s00109-019-01842-5.","journal-title":"J Mol Med (Berl)."},{"key":"1833_CR26","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3390\/jcm12062126","volume":"12","author":"J Pan","year":"2023","unstructured":"Pan J, Ding Y, Sun Y, et al. Associations between adipokines and metabolic dysfunction-associated fatty liver disease using three different diagnostic criteria. J Clin Med. 2023;12:2126. https:\/\/doi.org\/10.3390\/jcm12062126.","journal-title":"J Clin Med"},{"key":"1833_CR27","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1139\/apnm-2023-0457","volume":"49","author":"VH Ortenzi","year":"2024","unstructured":"Ortenzi VH, Oliveira AC, Vasconcelos RP, et al. High-fat diet elicits sex-based differences in liver inflammatory cytokines and redox homeostasis. Appl Physiol Nutr Metab. 2024;49:1083\u201392. https:\/\/doi.org\/10.1139\/apnm-2023-0457.","journal-title":"Appl Physiol Nutr Metab"},{"key":"1833_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/2470289718787091","volume":"2","author":"S H\u00f6rist-Kollmann","year":"2018","unstructured":"H\u00f6rist-Kollmann S, Strametz-Juranek J. Female dietary patterns and the pathogenesis of NAFLD. Gender and the Genome. 2018;2:49\u201355. https:\/\/doi.org\/10.1177\/2470289718787091.","journal-title":"Gender and the Genome"},{"key":"1833_CR29","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.3390\/healthcare12141396","volume":"12","author":"M Merino","year":"2024","unstructured":"Merino M, Tornero-Aguilera JF, Rubio-Zarapuz A, Villanueva-Tobaldo CV, Martin-Rodriguez A, Clemente-Suarez VJ. Body perceptions and psychological well-being: a review of the impact of social media and physical measurements on self-esteem and mental health with a focus on body image satisfaction and its relationship with cultural and gender factors. Healthcare (Basel). 2024;12:1396. https:\/\/doi.org\/10.3390\/healthcare12141396.","journal-title":"Healthcare (Basel)"},{"key":"1833_CR30","doi-asserted-by":"publisher","first-page":"1348456","DOI":"10.3389\/fnut.2024.1348456","volume":"11","author":"A Feraco","year":"2024","unstructured":"Feraco A, Armani A, Amoah I, et al. Assessing gender differences in food preferences and physical activity: a population-based survey. Front Nutr. 2024;11:1348456. https:\/\/doi.org\/10.3389\/fnut.2024.1348456.","journal-title":"Front Nutr"},{"key":"1833_CR31","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1016\/j.cgh.2021.11.001","volume":"20","author":"WY Park","year":"2022","unstructured":"Park WY, Yiannakou I, Petersen JM, Hoffmann U, Ma J, Long MT. Sugar-sweetened beverage, diet soda, and nonalcoholic fatty liver disease over 6 years: the Framingham heart study. Clin Gastroenterol Hepatol. 2022;20:2524\u201332.e2. https:\/\/doi.org\/10.1016\/j.cgh.2021.11.001.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1833_CR32","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.aohep.2023.101133","volume":"29","author":"ME Rinella","year":"2024","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol. 2024;29:101133. https:\/\/doi.org\/10.1016\/j.aohep.2023.101133.","journal-title":"Ann Hepatol"},{"key":"1833_CR33","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.3390\/jcm13133772","volume":"13","author":"R Curci","year":"2024","unstructured":"Curci R, Bonfiglio C, Franco I, Bagnato CB, Verrelli N, Bianco A. Leisure-time physical activity in subjects with metabolic-dysfunction-associated steatotic liver disease: an all-cause mortality study. J Clin Med. 2024;13:3772. https:\/\/doi.org\/10.3390\/jcm13133772.","journal-title":"J Clin Med"},{"key":"1833_CR34","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jacc.2023.12.019","volume":"83","author":"H Ji","year":"2024","unstructured":"Ji H, Gulati M, Huang TY, et al. Sex differences in association of physical activity with all-cause and cardiovascular mortality. J Am Coll Cardiol. 2024;83:783\u201393. https:\/\/doi.org\/10.1016\/j.jacc.2023.12.019.","journal-title":"J Am Coll Cardiol"},{"key":"1833_CR35","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s11136-010-9673-x","volume":"19","author":"D Cherepanov","year":"2010","unstructured":"Cherepanov D, Palta M, Fryback DG, Robert SA. Gender differences in health-related quality-of-life are partly explained by sociodemographic and socioeconomic variation between adult men and women in the US: evidence from four US nationally representative data sets. Qual Life Res. 2010;19:1115\u201324. https:\/\/doi.org\/10.1007\/s11136-010-9673-x.","journal-title":"Qual Life Res"},{"key":"1833_CR36","doi-asserted-by":"publisher","first-page":"11719","DOI":"10.1097\/MLR.0b013e3181354828","volume":"45","author":"J Hanmer","year":"2007","unstructured":"Hanmer J, Hays RD, Fryback DG. Mode of administration is important in US national estimates of health-related quality of life. MedCare. 2007;45:11719. https:\/\/doi.org\/10.1097\/MLR.0b013e3181354828.","journal-title":"MedCare"},{"key":"1833_CR37","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s10557-021-07273-0","volume":"36","author":"KA Peterson","year":"2022","unstructured":"Peterson KA, Kaur G, Gianos E, et al. Challenges in optimizing lipid management in women. Cardiovasc Drugs Ther. 2022;36:1197\u2013220. https:\/\/doi.org\/10.1007\/s10557-021-07273-0.","journal-title":"Cardiovasc Drugs Ther"},{"key":"1833_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00394-009-0053-7","volume":"49","author":"I Zazpe","year":"2010","unstructured":"Zazpe I, Estruch R, Toledo E, et al. Predictors of adherence to a Mediterranean-type diet in the PREDIMED trial. Eur J Nutr. 2010;49:91\u20139. https:\/\/doi.org\/10.1007\/s00394-009-0053-7.","journal-title":"Eur J Nutr"},{"key":"1833_CR39","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s11695-015-1746-z","volume":"26","author":"F Perrone","year":"2016","unstructured":"Perrone F, Bianciardi E, Benavoli D, et al. Gender influence on long-term weight loss and comorbidities after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: a prospective study with a 5-year follow-up. Obes Surg. 2016;26:276\u201381. https:\/\/doi.org\/10.1007\/s11695-015-1746-z.","journal-title":"Obes Surg"},{"key":"1833_CR40","doi-asserted-by":"publisher","unstructured":"Chrysavgis LG, Kazanas S, Bafa K, Rozani S, Koloutsou ME, Cholongitas E. Glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide, and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: novel medication in new liver disease nomenclature. Int J Mol Sci. 2024;25:3832. https:\/\/doi.org\/10.3390\/ijms25073832.","DOI":"10.3390\/ijms25073832"},{"key":"1833_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2016.06.009","volume":"24","author":"DJ Drucker","year":"2016","unstructured":"Drucker DJ. The cardiovascular biology of glucagon-like peptide-1. Cell Metab. 2016;24:15\u201330. https:\/\/doi.org\/10.1016\/j.cmet.2016.06.009.","journal-title":"Cell Metab"},{"key":"1833_CR42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/apt.15316","volume":"50","author":"P Newsome","year":"2019","unstructured":"Newsome P, Francque S, Harrison S, et al. Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and\/or obesity. Aliment Pharmacol Ther. 2019;50:193\u2013203. https:\/\/doi.org\/10.1111\/apt.15316.","journal-title":"Aliment Pharmacol Ther"},{"key":"1833_CR43","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s40262-015-0343-6","volume":"55","author":"LV Jacobsen","year":"2016","unstructured":"Jacobsen LV, Flint A, Olsen AK, Ingwersen SH. Liraglutide in type 2 diabetes mellitus: clinical pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2016;55:657\u201372. https:\/\/doi.org\/10.1007\/s40262-015-0343-6.","journal-title":"Clin Pharmacokinet"},{"key":"1833_CR44","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jdiacomp.2016.01.013","volume":"30","author":"H Quan","year":"2016","unstructured":"Quan H, Zhang H, Wei W, Fang T. Gender-related different effects of a combined therapy of exenatide and metformin on overweight or obesity patients with type 2 diabetes mellitus. J Diabetes Complicat. 2016;30:686\u201392. https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.01.013.","journal-title":"J Diabetes Complicat"},{"key":"1833_CR45","doi-asserted-by":"publisher","unstructured":"Borchers S, Skibicka KP. GLP-1 and its analogs: does sex matter? Endocrinology. 2025;166:bqae165. https:\/\/doi.org\/10.1210\/endocr\/bqae165.","DOI":"10.1210\/endocr\/bqae165"},{"key":"1833_CR46","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.tips.2024.05.004","volume":"45","author":"R Booijink","year":"2024","unstructured":"Booijink R, Ramachandran P, Bansal R. Implications of innate immune sexual dimorphism for MASLD pathogenesis and treatment. Trends Pharmacol Sci. 2024;45:614\u201327. https:\/\/doi.org\/10.1016\/j.tips.2024.05.004.","journal-title":"Trends Pharmacol Sci"},{"key":"1833_CR47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12916-023-02775-0","volume":"21","author":"D Liu","year":"2023","unstructured":"Liu D, Gao X, Pan XF, et al. The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome. BMC Med. 2023;21:62. https:\/\/doi.org\/10.1186\/s12916-023-02775-0.","journal-title":"BMC Med"},{"key":"1833_CR48","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3390\/jcm12030856","volume":"12","author":"R Manzano-Nunez","year":"2023","unstructured":"Manzano-Nunez R, Santana-Dominguez M, Rivera-Esteban J, et al. Non-alcoholic fatty liver disease in patients with polycystic ovary syndrome: a systematic review, meta-analysis, and meta-regression. J Clin Med. 2023;12:856. https:\/\/doi.org\/10.3390\/jcm12030856.","journal-title":"J Clin Med"},{"key":"1833_CR49","doi-asserted-by":"publisher","first-page":"100835","DOI":"10.1016\/j.jhepr.2023.100835","volume":"5","author":"PC Eng","year":"2023","unstructured":"Eng PC, Forlano R, Tan T, Manousou P, Dhillo WS, Izzi-Engbeaya C. Non-alcoholic fatty liver disease in women - current knowledge and emerging concepts. JHEP Rep. 2023;5:100835. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100835.","journal-title":"JHEP Rep"},{"key":"1833_CR50","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.3390\/ijms25084467","volume":"25","author":"M Vazquez-Carrera","year":"2024","unstructured":"Vazquez-Carrera M, Wahli W. PPARs as key transcription regulators at the crossroads of metabolism and inflammation. Int J Mol Sci. 2024;25:4467. https:\/\/doi.org\/10.3390\/ijms25084467.","journal-title":"Int J Mol Sci"},{"key":"1833_CR51","doi-asserted-by":"publisher","unstructured":"Yoon M. PPARalpha in obesity: sex difference and estrogen involvement.\u00a0PPAR Res. 2010;2010:584296.\u00a0\u00a0https:\/\/doi.org\/10.1155\/2010\/584296.","DOI":"10.1155\/2010\/584296"},{"key":"1833_CR52","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1172\/JCI88894","volume":"127","author":"V Dubois","year":"2017","unstructured":"Dubois V, Eeckhoute J, Lefebvre P, Staels B. Distinct but complementary contributions of PPAR isotypes to energy homeostasis. J Clin Invest. 2017;127:1202\u201314. https:\/\/doi.org\/10.1172\/JCI88894.","journal-title":"J Clin Invest"},{"key":"1833_CR53","doi-asserted-by":"publisher","unstructured":"Jalouli M, Carlsson L, Ameen C, et al. Sex difference in hepatic peroxisome proliferator-activated receptor alpha expression: influence of pituitary and gonadal hormones. Endocrinology. 2003;144:101\u20139. https:\/\/doi.org\/10.1210\/en.2002-220630.","DOI":"10.1210\/en.2002-220630"},{"key":"1833_CR54","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/gutjnl-2020-323323","volume":"71","author":"S Smati","year":"2022","unstructured":"Smati S, Polizzi A, Fougerat A, et al. Integrative study of diet-induced mouse models of NAFLD identifies PPARalpha as a sexually dimorphic drug target. Gut. 2022;71:807\u201321. https:\/\/doi.org\/10.1136\/gutjnl-2020-323323.","journal-title":"Gut"},{"key":"1833_CR55","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molmed.2007.06.001","volume":"13","author":"S Fiorucci","year":"2007","unstructured":"Fiorucci S, Rizzo G, Donini A, Distrutti E, Santucci L. Targeting farnesoid X receptor for liver and metabolic disorders. Trends Mol Med. 2007;13:298\u2013309. https:\/\/doi.org\/10.1016\/j.molmed.2007.06.001.","journal-title":"Trends Mol Med"},{"key":"1833_CR56","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/s41598-017-01576-9","volume":"7","author":"L Sheng","year":"2017","unstructured":"Sheng L, Jena PK, Liu HX, et al. Gender differences in bile acids and microbiota in relationship with gender dissimilarity in steatosis induced by diet and FXR inactivation. Sci Rep. 2017;7:1748. https:\/\/doi.org\/10.1038\/s41598-017-01576-9.","journal-title":"Sci Rep"},{"key":"1833_CR57","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1248\/bpb.b12-00868","volume":"36","author":"H Sato","year":"2013","unstructured":"Sato H, Sugai H, Kurosaki H, et al. The effect of sex hormones on peroxisome proliferator-activated receptor gamma expression and activity in mature adipocytes. Biol Pharm Bull. 2013;36:564\u201373. https:\/\/doi.org\/10.1248\/bpb.b12-00868.","journal-title":"Biol Pharm Bull"},{"key":"1833_CR58","unstructured":"Administration USFaD. FDA approves first treatment for patients with liver scarring due to fatty liver disease. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-patients-liver-scarring-due-fatty-liver-disease. Accessed 27 March 2025."},{"key":"1833_CR59","doi-asserted-by":"publisher","unstructured":"Muralidharan A, Gomez GA, Kesavan C, et al. Sex-specific effects of THRbeta signaling on metabolic responses to high fat diet in mice. Endocrinology. 2024;165:bqae075. https:\/\/doi.org\/10.1210\/endocr\/bqae075.","DOI":"10.1210\/endocr\/bqae075"},{"key":"1833_CR60","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1111\/jgh.16723","volume":"39","author":"NM Chee","year":"2024","unstructured":"Chee NM, Sinnanaidu RP, Chan WK. Vitamin E improves serum markers and histology in adults with metabolic dysfunction-associated steatotic liver disease: systematic review and meta-analysis. J Gastroenterol Hepatol. 2024;39:2545\u201354. https:\/\/doi.org\/10.1111\/jgh.16723.","journal-title":"J Gastroenterol Hepatol"},{"key":"1833_CR61","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.3748\/wjg.14.1598","volume":"14","author":"CL Wang","year":"2008","unstructured":"Wang CL, Liang L, Fu JF, et al. Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children. World J Gastroenterol. 2008;14:1598\u2013602. https:\/\/doi.org\/10.3748\/wjg.14.1598.","journal-title":"World J Gastroenterol"},{"key":"1833_CR62","doi-asserted-by":"publisher","unstructured":"Hirsova P, Gores GJ. Ballooned hepatocytes, undead cells, sonic hedgehog, and vitamin E: therapeutic implications for nonalcoholic steatohepatitis. Hepatology. 2015;61:15\u20137. https:\/\/doi.org\/10.1002\/hep.27279.","DOI":"10.1002\/hep.27279"},{"key":"1833_CR63","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10577-011-9254-z","volume":"20","author":"HL Franco","year":"2012","unstructured":"Franco HL, Yao HH. Sex and hedgehog: roles of genes in the hedgehog signaling pathway in mammalian sexual differentiation. Chromosome Res. 2012;20:247\u201358. https:\/\/doi.org\/10.1007\/s10577-011-9254-z.","journal-title":"Chromosome Res"},{"key":"1833_CR64","doi-asserted-by":"publisher","first-page":"CD015033","DOI":"10.1002\/14651858.CD015033.pub2","volume":"10","author":"H Wen","year":"2024","unstructured":"Wen H, Deng H, Yang L, et al. Vitamin E for people with non-alcoholic fatty liver disease. Cochrane Database Syst Rev. 2024;10:CD015033. https:\/\/doi.org\/10.1002\/14651858.CD015033.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1833_CR65","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.3390\/jcm13144243","volume":"13","author":"K Arvanitakis","year":"2024","unstructured":"Arvanitakis K, Chatzikalil E, Kalopitas G, et al. Metabolic dysfunction-associated steatotic liver disease and polycystic ovary syndrome: a complex interplay. J Clin Med. 2024;13:4243. https:\/\/doi.org\/10.3390\/jcm13144243.","journal-title":"J Clin Med"},{"key":"1833_CR66","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/09513590.2022.2079629","volume":"38","author":"S Yalle-Vasquez","year":"2022","unstructured":"Yalle-Vasquez S, Osco-Rosales K, Nieto-Gutierrez W, Benites-Zapata V, Perez-Lopez FR, Alarcon-Ruiz CA. Vitamin E supplementation improves testosterone, glucose- and lipid-related metabolism in women with polycystic ovary syndrome: a meta-analysis of randomized clinical trials. Gynecol Endocrinol. 2022;38:548\u201357. https:\/\/doi.org\/10.1080\/09513590.2022.2079629.","journal-title":"Gynecol Endocrinol"},{"key":"1833_CR67","doi-asserted-by":"publisher","unstructured":"Frank J, Lee S, Leonard SW, Atkinson JK, Kamal-Eldin A, Traber MG. Sex differences in the inhibition of gamma-tocopherol metabolism by a single dose of dietary sesame oil in healthy subjects. Am J Clin Nutr. 2008;87:1723\u20139. https:\/\/doi.org\/10.1093\/ajcn\/87.6.1723.","DOI":"10.1093\/ajcn\/87.6.1723"},{"key":"1833_CR68","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jgg.2021.09.009","volume":"49","author":"S Lu","year":"2022","unstructured":"Lu S, Wang Y, Liu J. Tumor necrosis factor-alpha signaling in nonalcoholic steatohepatitis and targeted therapies. J Genet Genomics. 2022;49:269\u201378. https:\/\/doi.org\/10.1016\/j.jgg.2021.09.009.","journal-title":"J Genet Genomics"},{"key":"1833_CR69","doi-asserted-by":"publisher","unstructured":"Song K, Kwon H, Han C, et al. Yes-associated protein in Kupffer cells enhances the production of proinflammatory cytokines and promotes the development of nonalcoholic steatohepatitis. Hepatology. 2020;72:72\u201387. https:\/\/doi.org\/10.1002\/hep.30990.","DOI":"10.1002\/hep.30990"},{"key":"1833_CR70","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10238-015-0347-4","volume":"16","author":"G Paredes-Turrubiarte","year":"2016","unstructured":"Paredes-Turrubiarte G, Gonzalez-Chavez A, Perez-Tamayo R, et al. Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients. Clin Exp Med. 2016;16:193\u2013202. https:\/\/doi.org\/10.1007\/s10238-015-0347-4.","journal-title":"Clin Exp Med"},{"key":"1833_CR71","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1055\/s-0043-118666","volume":"50","author":"S Kakino","year":"2018","unstructured":"Kakino S, Ohki T, Nakayama H, et al. Pivotal role of TNF-alpha in the development and progression of nonalcoholic fatty liver disease in a murine model. Horm Metab Res. 2018;50:80\u20137. https:\/\/doi.org\/10.1055\/s-0043-118666.","journal-title":"Horm Metab Res"},{"key":"1833_CR72","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fphar.2019.00047","volume":"10","author":"B Lagana","year":"2019","unstructured":"Lagana B, Zullo A, Scribano ML, et al. Sex differences in response to TNF-inhibiting drugs in patients with spondyloarthropathies or inflammatory bowel diseases. Front Pharmacol. 2019;10:47. https:\/\/doi.org\/10.3389\/fphar.2019.00047.","journal-title":"Front Pharmacol"},{"key":"1833_CR73","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1002\/ehf2.14151","volume":"9","author":"ME Haid","year":"2022","unstructured":"Haid ME, Zylla S, Paulista Markus MR, et al. Sex-specific associations of cardiorespiratory fitness and galectin-3 in the general population. ESC Heart Fail. 2022;9:4240\u20139. https:\/\/doi.org\/10.1002\/ehf2.14151.","journal-title":"ESC Heart Fail"},{"key":"1833_CR74","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3350\/cmh.2024.0359","volume":"31","author":"CJ Pirola","year":"2025","unstructured":"Pirola CJ, Landa MS, Schuman M, Garcia SI, Salatino A, Sookoian S. Metabolic dysfunction-associated steatotic liver disease exhibits sex-specific microbial heterogeneity within intestinal compartments. Clin Mol Hepatol. 2025;31:179\u201395. https:\/\/doi.org\/10.3350\/cmh.2024.0359.","journal-title":"Clin Mol Hepatol."},{"key":"1833_CR75","doi-asserted-by":"publisher","unstructured":"Shi J, Yang Y, Xu W, et al. Sex-specific associations between gut microbiome and non-alcoholic fatty liver disease among urban Chinese adults. Microorganisms. 2021;9:2118. https:\/\/doi.org\/10.3390\/microorganisms9102118.","DOI":"10.3390\/microorganisms9102118"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-025-01833-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-025-01833-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-025-01833-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:29:12Z","timestamp":1774366152000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-025-01833-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1833"],"URL":"https:\/\/doi.org\/10.1007\/s12664-025-01833-0","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Lisa B. VanWagner consults for Gerson Lehrman Group, Slingshot Insights and Alpha Insights previously served as an advisor for Madrigal Pharmaceuticals, receives research support from W.L. Gore & Associates and provides medicolegal consulting. All other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology\u00a0or the printer\/publishers are responsible for the results\/findings and content of this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}